| Molecular Formula | C6H5Cl2NO |
| Molar Mass | 178.02 |
| Melting Point | 159-161°C(lit.) |
| Boling Point | 252.9°C at 760 mmHg |
| Flash Point | 106.8°C |
| Water Solubility | almost transparency |
| Solubility | methanol: soluble50mg/mL, clear to hazy, colorless to light yellow |
| Vapor Presure | 0.0149mmHg at 25°C |
| Appearance | White-like powder |
| Color | Almost white to beige |
| BRN | 3626052 |
| Storage Condition | Inert atmosphere,Room Temperature |
| Sensitive | Moisture Sensitive |
| MDL | MFCD00012830 |
| Physical and Chemical Properties | Melting point 159-161°C(lit.) Sensitive moiety BRN 3626052 |
| Use | Pharmaceutical intermediates. |
| Hazard Symbols | C - Corrosive![]() |
| Risk Codes | 34 - Causes burns |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
| UN IDs | UN 3261 8/PG 2 |
| WGK Germany | 3 |
| HS Code | 29333990 |
| Hazard Note | Corrosive |
| Hazard Class | 8 |
| Packing Group | II |
| use | isocyanate chloride is a heterocyclic building block used to synthesize various drugs and biologically active compounds. It can be used to prepare tetrahydropyrroloquinoline ketone-type aromatase/aldosterone synthetase dual inhibitors as a new stage in breast cancer patients at risk of cardiovascular disease. use: pharmaceutical intermediates |